- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06119555
Effect of Cinnamon Powder Capsules on Body Composition
December 6, 2023 updated by: Muhammad Shahbaz, University of Veterinary and Animal Sciences, Lahore - Pakistan
Investigating the Impact of Consuming Cinnamon Powder on the Body Composition Among Obese University Students in Lahore
Obesity is a global health concern that significantly affects individuals, and its prevalence is still rising at an alarming rate.
While various treatments are available, they often come with unwanted side effects.
As a result, there is a growing interest in natural remedies including various herbs and spices such as cinnamon that have a favorable impact on overall health and disease conditions.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
Obesity is a global health concern that significantly affects individuals, and its prevalence is still rising at an alarming rate.
Pakistan is also experiencing an increasing prevalence of obesity, resulting in elevated morbidity, mortality, and healthcare costs.
While various treatments are available, they often come with negative side effects that can reduce a patient's quality of life.
Correspondingly, natural remedies have a kindle appeal that can enhance overall health and well-being.
In Pakistani culture, natural condiments have been used for their health and therapeutic benefits.
Cinnamon, an ancient spice commonly found in various regions, contains active ingredients that offer several health benefits.
However, there is limited scientific data regarding the effects of cinnamon on body composition, especially among obese university students in Pakistan.
Therefore, the current study aims to investigate the potential outcome of orally consuming cinnamon for weight management in obese university students in Pakistan.
As a result, the study may provide effective evidence-based strategies for maintaining healthy body weight and exploring the potential use of cinnamon as a natural treatment option.
Study Type
Interventional
Enrollment (Estimated)
54
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Ayesha Tariq Sindhu, BSc (Hons) Nutrition
- Phone Number: 03225884647
- Email: ayeshatariqsindhu@gmail.com
Study Locations
-
-
Punjab
-
Lahore, Punjab, Pakistan, 54000
- Recruiting
- University of Veterinary and Animal Sciences, Lahore - Pakistan
-
Contact:
- Dr. Hafiz Muhammad Shahbaz
- Phone Number: +92 344 4400660
- Email: muhammad.shahbaz@uvas.edu.pk
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Obese individuals (≥ 25 kg/m^2)
- University students of all disciplines
- Participants of 18-28 years
- Both male and female
Exclusion Criteria:
- Morbid obesity (BMI ≥30 kg/m^2)
- Disease conditions (such as cardiovascular diseases, diabetes, hypertension, renal disease, hypothyroidism, and hyperthyroidism)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Control Group
The control group will not receive intervention.
|
|
|
Experimental: Cinnamon Group
In the cinnamon group, participants will consume four cinnamon capsules daily for 60 days (each 1.5 grams, totaling 3 grams), two with breakfast and two with dinner.
|
The intervention consists of four cinnamon capsules (each 1.5 grams, totaling 3 grams) a day, with two with breakfast and two with dinner for 60 days
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Waist-to-hip ratio
Time Frame: 60 days
|
The waist-to-hip ratio will be assessment before and after intervention with cinnamon powder capsules for 60 days.
|
60 days
|
|
Body weight
Time Frame: 60 days
|
Body weight (Kg) will be assessed before and after intervention with cinnamon powder capsules for 60 days.
|
60 days
|
|
Skeletal muscle mass (SMM)
Time Frame: 60 days
|
Skeletal muscle mass (Kg) will be assessed before and after intervention with cinnamon powder capsules for 60 days.
|
60 days
|
|
Body fat mass
Time Frame: 60 days
|
Body fat mass (Kg) will be assessed before and after intervention with cinnamon powder capsules for 60 days.
|
60 days
|
|
Body mass index (BMI)
Time Frame: 60 days
|
Body mass index (Kg/m^2) will be assessed before and after intervention with cinnamon powder capsules for 60 days.
|
60 days
|
|
Percent body fat (PBF)
Time Frame: 60 days
|
Percent body fat (%) will be assessed before and after intervention with cinnamon powder capsules for 60 days.
|
60 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 25, 2023
Primary Completion (Estimated)
June 1, 2024
Study Completion (Estimated)
June 1, 2024
Study Registration Dates
First Submitted
October 31, 2023
First Submitted That Met QC Criteria
November 6, 2023
First Posted (Actual)
November 7, 2023
Study Record Updates
Last Update Posted (Estimated)
December 13, 2023
Last Update Submitted That Met QC Criteria
December 6, 2023
Last Verified
December 1, 2023
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- Cinnamon Bark Powder Capsules
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
All available data will be confidential
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Body Composition
-
Efforia, IncRecruiting
-
Dynamical Business and Science Society - DBSS International...Universidad de Córdoba; CES University; ARTHROS Centro de Fisioterapia y EjercicioRecruiting
-
Nova Southeastern UniversityCompleted
-
Centro Universitario de Ciencias de la Salud, MexicoCompleted
-
University of Southern CaliforniaCompleted
-
University of California, San FranciscoHologic, Inc.Completed
-
University of SurreyUnknownBody Composition
-
Texas Woman's UniversityCompleted
-
Efforia, IncRecruiting
-
Efforia, IncRecruiting
Clinical Trials on Cinnamon Capsules
-
Al-Kindy College of MedicineCompletedChronic Prostatitis | Chronic Pelvic Pain SyndromeIraq
-
Woman'sWoman's Hospital, Louisiana; Dietitians in Integrative and Functional Medicine...Withdrawn
-
Columbia UniversityUSDA Beltsville Human Nutrition Research Center; Integrity Neutraceuticals,...CompletedPolycystic Ovary SyndromeUnited States
-
Thames Valley UniversityWembley Health Care centre, NHS, UK.; Monks Park Primary care centre, NHS UK.; Willesden Health centre, NHS, UK...CompletedType 2 Diabetes MellitusUnited Kingdom
-
Egas Moniz - Cooperativa de Ensino Superior, CRLCompleted
-
Fenerbahce UniversityIstanbul University; Umraniye Education and Research HospitalNot yet recruitingPostoperative Nausea and Vomiting (PONV) | Intraperitoneal Chemotherapy | Peritoneal Metastases From Colorectal CancerTurkey (Türkiye)
-
Joslin Diabetes CenterKyunghee UniversityCompletedObesity | DysglycemiaUnited States
-
Clinical Nutrition Research Center, Illinois Institute...Completed
-
University of LimerickNational University of Ireland, Galway, Ireland; University of Ulster; Ulster...CompletedDiabetes Mellitus | Gastric EmptyingIreland
-
Dartmouth-Hitchcock Medical CenterDartmouth CollegeCompletedType 1 Diabetes MellitusUnited States